ArriVent

Pennsylvania Furnace, United States

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

May 2026

Post-IPO Equity

Top Investors

General CatalystHSGHillhouse InvestmentLilly Asia VenturesCatalio Capital Management

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are ArriVent's investors?

ArriVent's investors include General Catalyst, HSG, Hillhouse Investment, Lilly Asia Ventures, Catalio Capital Management.

Where is ArriVent headquartered?

ArriVent is headquartered in Pennsylvania Furnace, United States.

What does ArriVent do?

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

What stage is ArriVent at?

ArriVent is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 11, 2026.

MLA

"ArriVent — Funding & Investors." VCBacked, May 11, 2026, https://www.vcbacked.co/company/arrivent. Accessed June 3, 2026.

APA

VCBacked. (2026). ArriVent — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/arrivent

Wikipedia (cite web)

{{cite web |title=ArriVent — Funding & Investors |url=https://www.vcbacked.co/company/arrivent |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 11, 2026.